|Day Low/High||233.74 / 242.62|
|52 Wk Low/High||225.65 / 355.88|
Has the sun set on what was the greatest wealth creator of any company when the stock traded north of a trillion dollars? No.
Look for the big-cap stocks that only come in on tough days -- and take advantage of their weakness at the open.
Infrastructure and health care are likely to be in the political spotlight.
Now for those of you haven't voted, please go and do so and don't vote this stuff just invest in it!
Straying from these names could land you in quicksand as the 4th quarter begins.
Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.
It is all about perception, and here are strong names to pick up on market weakness.
Today's headlines may bring uncertainty, but this sector still looks good.
When rates decline, most of the S&P 500 benefits, according to TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.
Examining the charts of several names that are being bought and how to play them.
The crash of oil will only accelerate the move.
Consistency in discipline will make the difference.
These areas have little exposure to China, so buy them on any broad-market dip over U.S.-Chinese trade tensions.
Better-than-expected earnings will help soothe market jitters in the second quarter.
Are you ready to trade Monday? Here's what you must know as Wall Street returns from its long weekend.
Even if you love a stock that's down today, don't dive in all at once.
Sure, we love that companies are giving out one-time bonuses thanks to the lower rates from tax reform. But where are the actual wage increases? Watch out this video to find out.
Shares of Kindred Healthcare slipped after reaching an agreement to be acquired in a $4.1 billion deal.
Here's everything you need to get ready for the final trading week before the holidays.
Corporate buyers are now coming after sub-par companies.
This could also set off a chain reaction of similar deals.
Paul Kusserow, CEO of home health care provider Amedysis and a former Humana executive, thinks CVS Health's agreement to buy Aetna, announced on Monday, is "very exciting."